Summary by Futu AI
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.